Project Grant R43HG013914
Award Date
6/1/25
Completion Date
2/28/26
Dollars Obligated
$398K
Federal Agency
National Human Genome Research Institute
Awardee
Xgenomes Corp. (URQZNV343D65)
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports the development of a revolutionary DNA sequencing platform by Xgenomes Corp. The goal is to create a super-resolution single-molecule sequencing technology that can read short sequence "words" rather than individual DNA bases, enabling high-density sequencing with greater accuracy and lower costs than existing methods. The $384,418 award will fund a...
This $799,858 federal Project Grant awarded by the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) to Atlasxomics Inc. aims to develop a user-friendly, next-generation epigenomic chip that is adaptable to automation workflows. Specifically, the Phase I SBIR project will focus on expanding tissue type compatibility, minimizing end-user processing, and enabling adaptation into larger automation workflows for the company's spatial epigenomics platform. The effort...
This $1,234,692 Project Grant award from the National Human Genome Research Institute (NHGRI), under the 93.172 Human Genome Research Federal Grant Program, is supporting the development of a novel biomolecule imaging system called PRECYSE by Evizia Inc. The PRECYSE system leverages high-speed atomic force microscopy (HSAFM) to provide enhanced quality control capabilities for next-generation DNA sequencing library preparation. Key features include sizing DNA samples from 100 base pairs to...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded a $3,377,867 Project Grant to Survey Genomics, Inc. to develop and commercialize their innovative CYTOPE-DROP platform. This platform enables high-throughput, spatially-resolved single-cell multiomics analysis, allowing researchers to simultaneously profile mRNA abundances, protein abundances, and cell locations. The grant aims to further increase the spatial...
The National Human Genome Research Institute (NHGRI), under the Federal Grant Program "Human Genome Research" (CFDA 93.172), awarded a $407,291 Phase I Small Business Innovation Research (SBIR) grant to Electronic Biosciences, Inc. to develop a nanopore-based protein sequencing platform. The project aims to create a high-accuracy, label-free nanopore reader capable of direct, single-molecule protein sequencing. This novel technology would enable proteome-wide profiling, biomarker...
This federal Project Grant award of $743,524, awarded by the National Human Genome Research Institute (CFDA 93.172 Human Genome Research) and effective September 19, 2024, supports the development of "Expansion Genomics" - a new platform that leverages physical expansion of biological samples to increase the resolution of single-cell and spatial epigenomics techniques. The key objectives are to (1) develop "Single-Cell Expansion Genomics" to enable high-throughput,...
The National Human Genome Research Institute (NHGRI) awarded a $409,699 Project Grant (CFDA 93.172 - Human Genome Research) to the Regents of the University of Michigan on July 1, 2024. The grant, titled "INTEGRATING LC-MS/MS AND NANOPORE SEQUENCING PLATFORMS TO ENABLE THE DIRECT AND QUANTATATIVE DETECTION OF RNA MODIFICATIONS", will support research to develop methods for the quantitative detection of RNA modifications using a combination of liquid chromatography-tandem mass...
The federal Project Grant award, funded by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), supports the development of a CRISPR-based depletion technology by Jumpcode Genomics Inc. to improve the accuracy of next-generation sequencing (NGS)-based genetic testing. The $383,748 award aims to computationally design CRISPR guide RNAs and optimize depletion protocols to resolve ambiguity in variant calling caused by pseudogenes, which can...
The National Institute of General Medical Sciences (NIGMS) awarded a five-year, $1,127,364 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of California, Berkeley. The grant supports research to unlock the mechanisms of epigenetic memory in human cells, with a focus on understanding how DNA methylation patterns are established and how defects in these pathways contribute to disease. Key objectives include: Dissecting the roles of newly discovered genetic...
This federal Project Grant award, provided by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), is funding the development of a new nucleic acid extraction technology to enable high-quality DNA sequencing from formalin-fixed, paraffin-embedded tissue (FFPET) samples. The $1,020,280 grant, awarded on June 1, 2025 with a completion date of May 31, 2027, supports Vellum Biotechnology, Inc. in creating a robust, scalable epitachophoresis...